Ocrelizumab Shows Promise for Primary Progressive MS
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The MultipleSclerosis.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- Genentech’s Ocrelizumab First Investigational Medicine to Show Efficacy in People with Primary Progressive Multiple Sclerosis in Large Phase III Study. Genentech. Published September 27, 2015.
- Positive Results Announced from Phase III Clinical Trial of Ocrelizumab in Primary Progressive MS. National Multiple Sclerosis Society. Published September 28, 2015.
- Silva P. Could Genentech’s Ocrelizumab Become the First Effective Primary Progressive MS Therapy?. Multiple Sclerosis News Today. Published September 29, 2015.